Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selections from current literature: Recent developments in human HIV-1 vaccine.

D Dabelstein1, B Cromer

  • 1Department of Family Medicine, Health Science Center L-4, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.

Family Practice
|March 27, 2001
PubMed
Summary

Developing an effective human immunodeficiency virus (HIV) vaccine faces challenges due to diverse HIV serotypes. Current research combines gp120 envelope vaccines with canarypox vectors to broaden immune responses against this growing global health crisis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study.

Journal of pediatric and adolescent gynecology·2010
Same author

A role for the 2' residue in the second transmembrane helix of the GABA A receptor gamma2S subunit in channel conductance and gating.

The Journal of membrane biology·2005
Same author

In support of HRT.

Journal of pediatric and adolescent gynecology·2001
Same author

Abortion in adolescence: a four-country comparison.

Women's health issues : official publication of the Jacobs Institute of Women's Health·2001
Same author

Adolescents: at increased risk for osteoporosis?

Clinical pediatrics·2000
Same author

Selections from current literature. Recent advances in conjugated pneumococcal vaccination.

Family practice·2000

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • The global burden of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) remains a significant public health concern, with millions affected worldwide.
  • The year 2000 saw over 10,000 AIDS cases in the USA, and South Africa faces a severe epidemic, with projections indicating a substantial rise in HIV prevalence.
  • The existence of numerous HIV serotypes complicates the development of a universally effective vaccine.

Purpose of the Study:

  • To review recent advancements in the design of Human Immunodeficiency Virus type 1 (HIV-1) vaccines.
  • To examine established safety information for current HIV vaccines and discuss future ethical considerations.
  • To highlight promising research directions aimed at eliciting a broad immune response against HIV.

Related Experiment Videos

Main Methods:

  • Review of recent scientific literature on HIV vaccine design.
  • Analysis of safety data for existing vaccine candidates.
  • Exploration of novel vaccine strategies, including combination approaches.

Main Results:

  • Current HIV vaccine research is exploring the combination of gp120 envelope vaccines with canarypox vectors.
  • This combination strategy aims to elicit a broader immune response, addressing the challenge of diverse HIV serotypes.
  • Established safety profiles exist for current vaccine technologies, guiding future development.

Conclusions:

  • Developing a globally effective HIV vaccine is a complex, long-term endeavor due to viral diversity.
  • Continued scientific collaboration and resource allocation are crucial for advancing HIV vaccine development.
  • Future research will likely focus on combination vaccine strategies to achieve a more robust and widespread immune response.